Immunome
IMNM
IMNM
30 hedge funds and large institutions have $36.4M invested in Immunome in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
14% less funds holding
Funds holding: 35 → 30 (-5)
38% less capital invested
Capital invested by funds: $58.3M → $36.4M (-$22M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
30
Holding in Top 10
1
Calls
$1.45M
Puts
$553K
Top Buyers
| 1 | +$3.75M | |
| 2 | +$837K | |
| 3 | +$594K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$328K |
| 5 |
State Street
Boston,
Massachusetts
|
+$185K |
Top Sellers
| 1 | -$514K | |
| 2 | -$436K | |
| 3 | -$266K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$263K |
| 5 |
BIM
Baldwin Investment Management
West Conshohocken,
Pennsylvania
|
-$224K |